6.5 C
New York
Thursday, December 3, 2020

WHO calls for increased production of dexamethasone to treat severe forms of COVID-19

Must Read

Scientists explain the significance of the oldest sculptures on Earth

The statuettes of "Venus Figurines" personify the ideas of ancient people about the ideal female figure. Scientists from the United...

Astronomers catalog a million unknown galaxies and you can now take a virtual trip through them

Astronomers have cataloged a million previously unexplored galaxies using a radio telescope. The high-resolution images obtained were put together in...

The iOS, more vulnerable than ever: an iPhone could have been hacked over Wi-Fi

A cybersecurity expert finds an unprecedented vulnerability on iOS operating system devices. Until May 2020 the 'hackers' may have...
Manish Saini
Manish works as a Journalist and writer at Revyuh.com. He has studied Political Science and graduated from Delhi University. He is a Political engineer, fascinated by politics, and traditional businesses. He is also attached to many NGO's in the country and helping poor children to get the basic education. Email: Manish (at) revyuh (dot) com

The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, called for increased production of dexamethasone to treat critically ill patients with COVID-19.

“Although the data is preliminary, recent studies, showing that the steroid drug dexamethasone has the potential to save the lives of critically ill patients with COVID-19, give us reason to celebrate. The next challenge is to increase production and distribute dexamethasone rapidly and equitably around the world, with a focus on where it is most needed,” said Ghebreyesus.

According to the WHO chief, the demand for the drug is already outstripping the supply following successful trials in the UK.

“Luckily, that drug is not expensive and there are many dexamethasone producers around the world who are sure they can increase production,” added Ghebreyesus.

On June 16, Ghebreyesus called the first results of clinical trials of dexamethasone against COVID-19 in the United Kingdom a “scientific advance.”

According to the study carried out by the University of Oxford, this corticosteroid, normally used as an anti-inflammatory, reduces the risk of death in ventilator-connected patients by 35%, and that of patients receiving treatment with 20%. oxygen.

- Advertisement -
- Advertisement -

Latest News

Scientists explain the significance of the oldest sculptures on Earth

The statuettes of "Venus Figurines" personify the ideas of ancient people about the ideal female figure. Scientists from the United...

Astronomers catalog a million unknown galaxies and you can now take a virtual trip through them

Astronomers have cataloged a million previously unexplored galaxies using a radio telescope. The high-resolution images obtained were put together in an impressive celestial world map...

The iOS, more vulnerable than ever: an iPhone could have been hacked over Wi-Fi

A cybersecurity expert finds an unprecedented vulnerability on iOS operating system devices. Until May 2020 the 'hackers' may have accessed iPhones, iPads and iWatch...

German workers’ union declares war on Tesla

In Germany, the largest metalworkers union, IG Metall, declared war on Tesla co-founder Elon Musk who is building his first European plant in the...

A girl with a rare hair disease goes viral

A 10-year-old girl who was born with a rare genetic disease that makes it impossible for her to brush her hair has gone viral...
- Advertisement -

More Articles Like This

- Advertisement -